VolitionRx Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was USD 0.306392 million compared to USD 0.090035 million a year ago. Net loss was USD 30.27 million compared to USD 26.81 million a year ago.

Basic loss per share from continuing operations was USD 0.55 compared to USD 0.51 a year ago.